Your browser doesn't support javascript.
loading
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
Kipps, Thomas J; Fraser, Graeme; Coutre, Steven E; Brown, Jennifer R; Barrientos, Jacqueline C; Barr, Paul M; Byrd, John C; O'Brien, Susan M; Dilhuydy, Marie-Sarah; Hillmen, Peter; Jaeger, Ulrich; Moreno, Carol; Cramer, Paula; Stilgenbauer, Stephan; Chanan-Khan, Asher A; Mahler, Michelle; Salman, Mariya; Eckert, Karl; Solman, Isabelle G; Balasubramanian, Sriram; Cheng, Mei; Londhe, Anil; Ninomoto, Joi; Howes, Angela; James, Danelle F; Hallek, Michael.
Afiliação
  • Kipps TJ; UC San Diego Moores Cancer Center, La Jolla, CA. Electronic address: tkipps@ucsd.edu.
  • Fraser G; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
  • Coutre SE; Division of Hematology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA.
  • Brown JR; Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute, Boston, MA.
  • Barrientos JC; CLL Research and Treatment Program, Northwell Health Cancer Institute, Hempstead, NY.
  • Barr PM; University of Rochester, Rochester, NY.
  • Byrd JC; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA.
  • Dilhuydy MS; Hôpital Haut-Lévêque, Pessac, France.
  • Hillmen P; University of Leeds, Leeds, UK.
  • Jaeger U; Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Cramer P; Department of Internal Medicine and German CLL Study Group, University of Cologne, Cologne, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Chanan-Khan AA; Division of Hematology, Mayo Clinic Cancer Center, Jacksonville, FL.
  • Mahler M; Janssen Research and Development, Horsham, PA.
  • Salman M; Janssen Research and Development, Horsham, PA.
  • Eckert K; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Solman IG; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Balasubramanian S; Janssen Research and Development, Horsham, PA.
  • Cheng M; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Londhe A; Janssen Research and Development, Horsham, PA.
  • Ninomoto J; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Howes A; Janssen Research and Development, Horsham, PA.
  • James DF; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA.
  • Hallek M; Department of Internal Medicine and German CLL Study Group, University of Cologne, Cologne, Germany.
Clin Lymphoma Myeloma Leuk ; 19(11): 715-722.e6, 2019 11.
Article em En | MEDLINE | ID: mdl-31447270
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Cromossomos Humanos Par 11 / Leucemia Linfocítica Crônica de Células B / Deleção Cromossômica / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Cromossomos Humanos Par 11 / Leucemia Linfocítica Crônica de Células B / Deleção Cromossômica / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article